Results 331 to 340 of about 419,003 (365)
Some of the next articles are maybe not open access.
Gastroenterology, 2013
BACKGROUND & AIMS Patients with cirrhosis hospitalized for an acute decompensation (AD) and organ failure are at risk for imminent death and considered to have acute-on-chronic liver failure (ACLF).
R. Moreau +17 more
semanticscholar +1 more source
BACKGROUND & AIMS Patients with cirrhosis hospitalized for an acute decompensation (AD) and organ failure are at risk for imminent death and considered to have acute-on-chronic liver failure (ACLF).
R. Moreau +17 more
semanticscholar +1 more source
Infectious Disease Clinics of North America, 2001
Infection is a well-described complication of cirrhosis and is a major cause of death in this population. This article examines the types of infections related with cirrhosis, such as bacteremia, urinary tract infections, meningitis, and others.
Diane H. Johnson, Burke A. Cunha
openaire +3 more sources
Infection is a well-described complication of cirrhosis and is a major cause of death in this population. This article examines the types of infections related with cirrhosis, such as bacteremia, urinary tract infections, meningitis, and others.
Diane H. Johnson, Burke A. Cunha
openaire +3 more sources
Current Gastroenterology Reports, 2019
This review discusses the prevalence of malnutrition in cirrhosis, metabolic functions of the liver and alterations in cirrhosis, malnutrition screening tools, and common macronutrient and micronutrient deficiencies encountered in individuals with chronic liver disease and their impact on morbidity and mortality.Several meta-analyses and international ...
Gabriela Kuftinec +3 more
openaire +3 more sources
This review discusses the prevalence of malnutrition in cirrhosis, metabolic functions of the liver and alterations in cirrhosis, malnutrition screening tools, and common macronutrient and micronutrient deficiencies encountered in individuals with chronic liver disease and their impact on morbidity and mortality.Several meta-analyses and international ...
Gabriela Kuftinec +3 more
openaire +3 more sources
Disease-a-Month, 1954
SINCE Laennec1 (1869) defined cirrhosis of the liver, it has become apparent that the disease may occur in a variety of clinical and pathological forms. Accepted etiologic factors contribute to hepatic disease in hemochromatosis, Wilson's disease and biliary or cardiac cirrhosis, but the cause of cirrhosis in the majority of patients remains uncertain.
openaire +5 more sources
SINCE Laennec1 (1869) defined cirrhosis of the liver, it has become apparent that the disease may occur in a variety of clinical and pathological forms. Accepted etiologic factors contribute to hepatic disease in hemochromatosis, Wilson's disease and biliary or cardiac cirrhosis, but the cause of cirrhosis in the majority of patients remains uncertain.
openaire +5 more sources
Disease-a-Month, 2008
common causes of cirrhosis in the United States are alcoholic liver disease and chronic viral hepatitis. Other causes of cirrhosis are shown in Table 1. The pathogenesis of fibrosis is complex and largely unknown, but central to the process is inflammation and subsequent repair. Local and distal inflammatory cells are recruited, and tissue fibroblasts (
Sammy Saab, Mamie H. Dong
openaire +3 more sources
common causes of cirrhosis in the United States are alcoholic liver disease and chronic viral hepatitis. Other causes of cirrhosis are shown in Table 1. The pathogenesis of fibrosis is complex and largely unknown, but central to the process is inflammation and subsequent repair. Local and distal inflammatory cells are recruited, and tissue fibroblasts (
Sammy Saab, Mamie H. Dong
openaire +3 more sources
AGA Clinical Practice Update: Coagulation in Cirrhosis.
Gastroenterology, 2019DESCRIPTION This expert review was commissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership.
J. O’Leary +3 more
semanticscholar +1 more source
Gastroenterology, 2019
Portal vein thrombosis unrelated to solid malignancy is common in patients with cirrhosis, but less frequently observed in patients without cirrhosis. Prompt diagnosis and management of acute symptomatic portal vein thrombosis are essential.
N. Intagliata, S. Caldwell, A. Tripodi
semanticscholar +1 more source
Portal vein thrombosis unrelated to solid malignancy is common in patients with cirrhosis, but less frequently observed in patients without cirrhosis. Prompt diagnosis and management of acute symptomatic portal vein thrombosis are essential.
N. Intagliata, S. Caldwell, A. Tripodi
semanticscholar +1 more source
Scintiphotography in Cirrhosis
Archives of Internal Medicine, 1968Gamma camera scintiphotography was employed to study 30 patients with alcoholic liver disease. Marked hepatomegaly was found in 40% and abnormally small livers in 27%. Splenic uptake was significant and demonstrable in 60% of the patients. Only 10% had palpable spleens.
Donald Golden +3 more
openaire +3 more sources
The American Journal of Nursing, 1965
T.aennec named the firm, diffusely fibrotic liver with its orange-colored projecting nodules "cirrhosis," after the Greek word kirrhos, meaning orange. Other synonyms are portal cirrhosis, alcoholic (ethanolic) cirrhosis, fatty cirrhosis, atrophic cirrhosis, and "gin drinker's liver." Laennec's cirrhosis is a pathologic entity in which a varying degree
Mary T. Bielski, David W. Molander
openaire +3 more sources
T.aennec named the firm, diffusely fibrotic liver with its orange-colored projecting nodules "cirrhosis," after the Greek word kirrhos, meaning orange. Other synonyms are portal cirrhosis, alcoholic (ethanolic) cirrhosis, fatty cirrhosis, atrophic cirrhosis, and "gin drinker's liver." Laennec's cirrhosis is a pathologic entity in which a varying degree
Mary T. Bielski, David W. Molander
openaire +3 more sources
Gastroenterology, 2018
BACKGROUND & AIMS Lysyl oxidase-like 2 contributes to fibrogenesis by catalyzing cross-linkage of collagen. We evaluated the safety and efficacy of simtuzumab, a monoclonal antibody against lysyl oxidase-like 2, in two phase 2b trials of patients with ...
Stephen A. Harrison +20 more
semanticscholar +1 more source
BACKGROUND & AIMS Lysyl oxidase-like 2 contributes to fibrogenesis by catalyzing cross-linkage of collagen. We evaluated the safety and efficacy of simtuzumab, a monoclonal antibody against lysyl oxidase-like 2, in two phase 2b trials of patients with ...
Stephen A. Harrison +20 more
semanticscholar +1 more source